Cell Analysis Market in terms of revenue was estimated to be worth $20.2 billion in 2023 and is poised to reach $33.9 billion by 2028, growing at a CAGR of 10.9% from 2023 to 2028 according to a new report by MarketsandMarkets™. Rising preference for cell-based assays in drug discovery serves as one of the key driving factors of the cell analysis market. Pharmaceutical & biotechnology companies and CROs are replacing biochemical assays with cell-based assays for their lead identification and optimization processes in drug discovery. This is attributive to the several advantages over in vitro biochemical assays. They offer consistent tissue-specific responses in a biologically relevant microenvironment as opposed to biochemical assays.
Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157543946
The cell analysis industry is poised to experience unprecedented growth and innovation in the near future. With advancements in technology and increasing demand for personalized medicine, the field of cell analysis is expected to revolutionize healthcare and scientific research. Cutting-edge techniques such as single-cell analysis, high-throughput screening, and multi-omics integration are set to provide unparalleled insights into cellular behaviour and disease mechanisms.
The software segment is estimated to grow at the fastest pace through the forecast period
Based on product & service, the global cell analysis market is segmented into reagents & consumables, instruments, accessories, software, and services. The software segment is a lucrative space owing to the advancements across single-cell analysis and flow cytometry techniques. This has elevated the influx of emerging companies entering cell analysis industry. Emerging companies building innovative software solutions has contributed to the robust growth rate registered by this segment.
The flow cytometry technique segment accounted for the largest share in the cell analysis market in 2022
Based on technique, the global cell analysis market is segmented into flow cytometry, PCR, cell microarrays, microscopy, spectrophotometry, high-content screening, and other techniques. The flow cytometry segment accounted for the largest market share of in 2022. Significant demand for flow cytometry technique across single-cell analysis and other different analysis processes is set to propel the market growth. Through flow cytometry multiple characteristics of single-cell particles can be measured and analyzed making it a preferable cell analysis technique for fluid samples.
The hospitals & clinical testing laboratories segment is estimated to grow with highest CAGR during the forecast period of cell analysis market
On the basis of end users, the cell analysis market is segmented into pharmaceutical & biotechnology companies, hospitals & clinical testing laboratories, academic & research institutes, and other end users. The demand for cell analysis products is set to elevate across in-house diagnostic and research centers, in-house pathology centers, and reference laboratories; collectively contributing to the fastest growth rate of hospitals & clinical testing laboratories during the forecast period. The development of highly specialized and complex cell-based assays is expected to supplement this growth.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=157543946
Asia Pacific has registered fastest growth rate during the forecast period in cell analysis market
The global cell analysis market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. Rapid increase in the pharmaceutical & biopharmaceutical industries coupled with affordable with cell analysis services are the key contributing factors to the regional growth.
Key Market Players:
The cell analysis market is fragmented in nature with prominent players operating in this market such as Danaher (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), General Electric (US), Merck KGaA (US), Agilent Technologies (US), Olympus Corporation (Japan), Miltenyi Biotec (US), Bio-Rad Laboratories (US), BioStatus Limited (UK), Fluidigm Corporation (US), NanoCellect Biomedical (US), Cell Biolabs (US), Creative Bioarray (US), Meiji Techno (US), Promega Corporation (US), PerkinElmer (US), Tecan Trading AG (Switzerland), CELLINK (US), QIAGEN (Germany), Corning Incorporated (US), 10x Genomics (US), and Illumina (US).
Recent Developments:
- In 2023, Becton, Dickinson and Company (US) launched a Spectral Cell Sorter that is coupled with high-speed cell imaging. this product combines real-time imaging technology with spectral flow cytometry.
Get 10% Free Customization on this Report: https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=157543946
Media Contact
Company Name: MarketsandMarkets™ Research Private Ltd.
Contact Person: Mr. Aashish Mehra
Email: Send Email
Phone: 18886006441
Address:630 Dundee Road Suite 430
City: Northbrook
State: IL 60062
Country: United States
Website: https://www.marketsandmarkets.com/Market-Reports/cell-analysis-market-157543946.html